Open | $23.230 |
Close | $24.310 |
Volume / Avg. | 1.608M / 1.589M |
Day Range | 23.010 - 25.000 |
52 Wk Range | 20.540 - 34.275 |
Market Cap | $2.503B |
P/E Ratio | 25.862 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 60 |
Short Interest | 30.49% |
Days to Cover | 13.17 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Corcept Therapeutics (NASDAQ: CORT) through any online brokerage.
Other companies in Corcept Therapeutics’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), CymaBay Therapeutics (NASDAQ:CBAY), Neumora Therapeutics (NASDAQ:NMRA) and ANI Pharmaceuticals (NASDAQ:ANIP).
The latest price target for Corcept Therapeutics (NASDAQ: CORT) was reported by Truist Securities on Friday, February 16, 2024. The analyst firm set a price target for 42.00 expecting CORT to rise to within 12 months (a possible 73.70% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Corcept Therapeutics (NASDAQ: CORT) is $24.18 last updated March 18, 2024 at 4:30 PM EDT.
There are no upcoming dividends for Corcept Therapeutics.
Corcept Therapeutics’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for Corcept Therapeutics.
Corcept Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.